题名

The Effect of Applying Clinical Pathways on Medical Resource Utilization among Patients Undergoing a Thyroidectomy

并列篇名

臨床路徑對甲狀腺切除術之醫療資源利用的影響

DOI

10.6226/NTUMR.202304_33(1).0005

作者

Li-Fei Pan(潘麗馡);Wen-Der Lin(林文德);Pei-Ling Tang(唐佩玲);Wun-Rong Yan(顏文榮);Chaohsin Lin(林兆欣);Shuofen Hsu(許碩芬)

关键词

case payment ; Clinical Pathways (CPs) ; thyroidectomy ; Length of Stay (LOS) ; medical expenses ; 論病例計酬 ; 臨床路徑 ; 甲狀腺切除術 ; 住院天數 ; 醫療費用

期刊名称

臺大管理論叢

卷期/出版年月

33卷1期(2023 / 04 / 01)

页次

163 - 189

内容语文

英文;繁體中文

中文摘要

Taiwan's National Health Insurance Administration (NHIA) began large-scale implementing the case payment method from 1997 with a view to reducing inpatient costs. Hospitals have adopted several management control systems such as Clinical Pathways (CPs) in response to the challenges of maintaining both fiscal soundness and the quality of medical care. The objective of this study is to assess the effects of CPs on the utilization of medical resources, particularly on the practice of thyroidectomy. We evaluate a total of 376 case payments for thyroidectomies operating in an academic medical center from 2001 to 2003 and compare differences between pre- and post-CPs implementation in terms of medical costs and Length of Stay (LOS). The empirical results show that after the implementation of the CPs, the reductions in LOS (31.90%) and in medical expenditure (14.98%) within the General Surgery (GS) department are statistically significant. In addition, the medical resource utilization in the GS division with CPs is significantly lower than that in the Ear, Nose, and Throat (ENT) division without implementing such a program. This study demonstrates that the CPs reduce hospital costs and improve the standard of medical care for patients. Further research is warranted to investigate the cost-effectiveness of CPs implementation and the potential risk of cost shifting from the inpatient to outpatient departments.

英文摘要

臺灣健保自1997年大規模實施論病例計酬制度以來,各醫院開始採取成本管控措施,如發展臨床路徑來降低醫療成本並維持醫療品質。本文採用回溯性及觀察性研究,以接受甲狀腺切除術的患者資料為例,探討實施臨床路徑對醫療資源耗用的影響。我們收集了2001至2003年某醫學中心376位接受甲狀腺切除術、論病例計酬的病患為研究對象,比較臨床路徑實施前後,其醫療費用和住院天數的差異。實證結果顯示,一般外科在實施臨床路徑後,平均住院天數及平均住院醫療費用均顯著下降(分別為31.90%及14.98%)。此外,實施臨床路徑的一般外科之醫療資源耗用情形,也明顯低於未實施該項目的耳鼻喉科。本研究證實,臨床路徑可有效降低醫療費用並提高患者的醫療品質。未來可進一步研究實施臨床路徑的成本效益,以及其成本可能從住院部轉移到門診部的潛在風險。

主题分类 基礎與應用科學 > 資訊科學
基礎與應用科學 > 統計
社會科學 > 經濟學
社會科學 > 財金及會計學
社會科學 > 管理學
参考文献
  1. Ou, C. S.,Chao, L. H.,Hung, C. S.,Lin, H. M.(2012).A study of the impacts of national health insurance on operating efficiencies of medical institutions.NTU Management Review,22(2),253-276.
    連結:
  2. Al-Qurayshi, Z.,Robins, R.,Hauch, A.,Randolph, G. W.,Kandil, E.(2016).Association of surgeon volume with outcomes and cost savings following thyroidectomy: A national forecast.JAMA Otolaryngology-Head & Neck Surgery,142(1),32-39.
  3. Aschebrook-Kilfoy, B.,Schechter, R. B.,Shih, Y. C.,Kaplan, E. L.,Chiu, B. C. H.,Angelos, P.,Grogan, R. H.(2013).The clinical and economic burden of a sustained increase in thyroid cancer incidence.Cancer Epidemiology, Biomarkers & Prevention,22(7),1252-1259.
  4. Athey, S.,Imbens, G. W.(2017).The econometrics of randomized experiments.Handbook of Economic Field Experiments,Amsterdam, Netherlands:
  5. Ayalon, O.,Liu, S.,Flics, S.,Cahill, J.,Juliano, K.,Cornell, C. N.(2011).A multimodal clinical pathway can reduce length of stay after total knee arthroplasty.HSS Journal: The Musculoskeletal Journal of Hospital for Special Surgery,7(1),9-15.
  6. Cieza, A.,Causey, K.,Kamenov, K.,Hanson, S. W.,Chatterji, S.,Vos, T.(2020).Global estimates of the need for rehabilitation based on the Global Burden of Disease Study 2019: A systematic analysis for the Global Burden of Disease Study 2019.The Lancet,396(10267),2006-2017.
  7. Coscia, F.,Taler-Verčič, A.,Chang, V. T.,Sinn, L.,O’Reilly, F. J.,Izoré, T.,Renko, M.,Berger, I.,Rappsilber, J.,Turk, D.,Löwe, J.(2020).The structure of human thyroglobulin.Nature,578(7796),627-630.
  8. De Bleser, L.,Depreitere, R.,De Waele, K.,Vanhaecht, K.,Vlayen, J.,Sermeus, W.(2006).Defining pathways.Journal of Nursing Management,14(7),553-563.
  9. De Nardi, M.,French, E.,Jones, J. B.,McCauley, J.(2016).Medical spending of the US elderly.Fiscal Studies,37(3-4),717-747.
  10. Deyo, R. A.,Cherkin, D. C.,Ciol, M. A.(1992).Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.Journal of Clinical Epidemiology,45(6),613-619.
  11. Erbil, Y.,Barbaros, U.,Işsever, H.,Borucu, I.,Salmaslioğlu, A.,Mete, Ö.,Bozbora, A.,Özarmağan, S.(2007).Predictive factors for recurrent laryngeal nerve palsy and hypoparathyroidism after thyroid surgery.Clinical Otolaryngology,32(1),32-37.
  12. Famà, F,Linard, C.,Patti, R.,Berry, M. G.,Gioffrè-Florio, M.,Piquard, A.,Saint-Marc, O.(2013).Short-stay hospitalisation for benign thyroid surgery: A prospective study.European Archives of Oto-Rhino-Laryngology,270(1),301-304.
  13. Feroci, F.,Lenzi, E.,Baraghini, M.,Garzi, A.,Vannucchi, A.,Cantafio, S.,Scatizzi, M.(2013).Fast-track surgery in real life: How patient factors influence outcomes and compliance with an enhanced recovery clinical pathway after colorectal surgery.Surgical Laparoscopy Endoscopy & Percutaneous Techniques,23(3),259-265.
  14. Health Promotion Administration, Ministry of Health and Welfare. 2020. Cancer Registry Annual Report, 2020 TAIWAN. https://www.hpa.gov.tw/Pages/List.aspx?nodeid=269. Accessed Jan. 17, 2023.
  15. Helfand, M.,Redfern, C. C.(1998).Screening for thyroid disease: An update.Annals of Internal Medicine,129(2),144-158.
  16. Jones, A. M.,Glied, S.(2009).Econometric evaluation of health policies.The Oxford Handbook of Health Economics,Oxford, UK:
  17. Kulkarni, R. P.,Ituarte, P. H. G.,Gunderson, D.,Yeh, M. W.(2011).Clinical pathways improve hospital resource use in endocrine surgery.Journal of the American College of Surgeons,212(1),35-41.
  18. Kwon, H.,Lee, J. H.,Woo, J.,Lim, W.,Moon, B. I.,Paik, N. S.(2018).Efficacy of a clinical pathway for patients with thyroid cancer.Head & Neck,40(9),1909-1916.
  19. Li, M.,Dal Maso, L.,Vaccarella, S.(2020).Global trends in thyroid cancer incidence and the impact of overdiagnosis.The Lancet Diabetes & Endocrinology,8(6),468-470.
  20. Lin, C.,Hsu, S.(2014).Constructing "behavioral" comparison groups: A difference-in-difference analysis of the effect of copayment based on the patient’s price elasticity.Evaluation & the Health Professions,37(4),434-456.
  21. Lubitz, C. C.,Kong, C. Y.,McMahon, P. M.,Daniels, G. H.,Chen, Y.,Economopoulos, K. P.,Gazelle, G. S.,Weinstein, M. C.(2014).Annual financial impact of well-differentiated thyroid cancer care in the United States.Cancer,120(9),1345-1352.
  22. McPhail, S. M.(2016).Multimorbidity in chronic disease: Impact on health care resources and costs.Risk Management and Healthcare Policy,9,143-156.
  23. Ministry of Health and Welfare. 2015. The Statistics and Trends in Health and Welfare 2015. https://www.mohw.gov.tw/lp-3570-2.html. Accessed Feb 28, 2022.
  24. Ministry of Health and Welfare. 2022. National Health Expenditure 2020 Abstract. https://www.mohw.gov.tw/lp-130-2.html. Accessed Jun. 14, 2022.
  25. Partridge, L.,Deelen, J.,Slagboom, P. E.(2018).Facing up to the global challenges of ageing.Nature,561(7721),45-56.
  26. Rotter, T.,Kinsman, L.,James, E.,Machotta, A.,Willis, J.,Snow, P.,Kugler, J.(2012).The effects of clinical pathways on professional practice, patient outcomes, length of stay, and hospital costs: Cochrane systematic review and meta-analysis.Evaluation & the Health Professions,35(1),3-27.
  27. Schwarzbach, M.,Rössner, E.,Schattenberg, T.,Post, S.,Hohenberger, P.,Ronellenfitsch, U.(2010).Effects of a clinical pathway of pulmonary lobectomy and bilobectomy on quality and cost of care.Langenbeck’s Archives of Surgery,395(8),1139-1146.
  28. Seo, H. S.,Song, K. Y.,Jeon, H. M.,Park, C. H.(2012).The impact of an increased application of critical pathway for gastrectomy on the length of stay and cost.Journal of Gastric Cancer,12(2),126-131.
  29. Song, Z.,Ji, Y.,Safran, D. G.,Chernew, M. E.(2019).Health care spending, utilization, and quality 8 years into global payment.New England Journal of Medicine,381(3),252-263.
  30. van Dam, P. A.,Verheyden, G.,Sugihara, A.,Trinh, X. B.,Van Der Mussele, H.,Wuyts, H.,Verkinderen, L.,Hauspy, J.,Vermeulen, P.,Dirix, L.(2013).A dynamic clinical pathway for the treatment of patients with early breast cancer is a tool for better cancer care: Implementation and prospective analysis between 2002-2010.World Journal of Surgical Oncology,11(1),70.
  31. Wooldridge, J. M.(2012).Introductory Econometrics: A Modern Approach.Boston, MA:Cengage Learning.
  32. Yang, Y.,Hu, X.,Zhang, Q.,Cao, H.,Li, J.,Wang, J.,Shao, Y.,Xin, S.(2016).Effect of clinical nursing pathway for endoscopic thyroidectomy in Chinese patients: A meta-analysis.International Journal of Nursing Practice,22(3),224-231.
  33. Younossi, Z. M.,Otgonsuren, M.,Henry, L.,Arsalla, Z.,Stepnaova, M.,Mishra, A.,Venkatesan, C.,Hunt, S.(2015).Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States.Journal of Viral Hepatitis,22(2),137-145.